Trials / Withdrawn
WithdrawnNCT02220972
To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This will be a multi-center, randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of 2007/Fycompa (perampanel) on sleep, in subjects with well controlled partial onset seizures (on an antiepileptic drug \[AED\] monotherapy) who are experiencing sleep onset insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perampanel | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2014-08-20
- Last updated
- 2015-02-10
Source: ClinicalTrials.gov record NCT02220972. Inclusion in this directory is not an endorsement.